Klotho Neurosciences Inc. Ordinary Shares KLTO 深 滬
等待開盤 11-26 09:30:00 美东时间
0.4936
-0.003
-0.68%
華盛通- 最 高0.51
- 今 開0.50
- 成交量 68.58万股
- 最 低 0.4893
- 昨 收 0.497
- 總市值 273.31万
- 52周最高 3.9099
- 市盈率 靜 --
- 換手率 12.39%
- 52周最低 0.1135
- 委 比 -98.47%
- 總股本 553.70万
- 歷史最高 13.10
- 量 比 0.70
- 振 幅 4.16%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Klotho Neurosciences Q3 EPS $(0.05) Up From $(0.18) YoY
Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.05) per share. This is a 72.22 percent increase over losses of $(0.18) per share from the same period last year.
11-14 06:42
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") a U.S.-based biogenetics company, announces that members of its leadership team ...
10-16 20:00
Klotho Neurosciences Announces Expiration of Letter of Intent
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed t...
10-08 06:20
Klotho Neurosciences to acquire select assets from Turn Biotechnologies
Klotho Neurosciences (NASDAQ:KLTO) said on Tuesday that it has signed a Letter of Intent (LOI) to acquire select assets from Turn Biotechnologies. Under the LOI, Klotho would acquire Turn's ERA ("Epi...
09-30 21:25
Klotho Neurosciences Faces Nasdaq Delisting Notice
The latest update is out from Klotho Neurosciences ( ($KLTO) ). On September 19...
09-26 04:54
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerati...
09-08 20:00
Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Docusign Inc (NASDAQ:DOCU) rose sharply in pre-market trading after t...
09-05 17:20
Klotho Neurosciences Q2 EPS $(0.12) Down From $(0.03) YoY
Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.12) per share. This is a 300 percent decrease over losses of $(0.03) per share from the same period last year.
08-18 21:50
Klotho Neurosciences Highlights Pipeline Progress Toward $8B Neurodegenerative Market; Accelerates KLTO-202 Preclinical and IND-Enabling Studies
Key partnerships, regulatory progress, manufacturing advancements, along with significant capital infusion accelerate the development of Klotho-based therapeuticsNEW YORK, Aug. 18, 2025 /PRNewswire/ -- Klotho
08-18 20:37
Klotho Neurosciences shares are trading higher after the company announced it will partner with AAVnerGene to manufacture gene therapy assets.
Klotho Neurosciences shares are trading higher after the company announced it w...
07-23 02:51
